Furthermore, a recent study in the bleomycin-induced scleroderma mouse model demonstrated that inhibition of BAFF attenuates skin and lung fibrosis with reduction of IL-6–producing effector B cells [75]. The gene discussed is IL6; the disease is pulmonary fibrosis.